(Q37440391)

20 August 2017

Planning multi-arm screening studies within the context of a drug development program (English)

1 reference

20 August 2017

0 references

Nigel Stallard

3

0 references

author name string

James M S Wason

series ordinal

1

1 reference

20 August 2017

Thomas Jaki

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

26 March 2013

1 reference

20 August 2017

Statistics in Medicine

1 reference

20 August 2017

32

1 reference

20 August 2017

20

1 reference

20 August 2017

3424-3435

1 reference

Some recommendations for multi-arm multi-stage trials

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Adaptive designs for confirmatory clinical trials

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Testing and estimation in flexible group sequential designs with adaptive treatment selection

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

The price of innovation: new estimates of drug development costs

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Optimal multistage designs for randomised clinical trials with continuous outcomes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

A two-stage design for choosing among several experimental treatments and a control in clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Optimal design of multi-arm multi-stage trials

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Optimal sample sizes for phase II clinical trials and pilot studies.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

On sample size determination in multi-armed confirmatory adaptive designs

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Group sequential clinical trials with triangular continuation regions.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Designing phase II studies in the context of a programme of clinical research

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3882502

Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis

2 September 2018

1 reference

A Simplex Method for Function Minimization

21 January 2018

1 reference

A Comparison of Methods for Adaptive Treatment Selection

21 January 2018

1 reference

A group-sequential design for clinical trials with treatment selection

21 January 2018

1 reference

Sample sizes for phase II and phase III clinical trials: an integrated approach

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23529936

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/SIM.5787

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

23529936

1 reference